SEC Form 4 · accession 0001615774-15-000552
Vivani Medical, Inc. · VANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J. Greenberg
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Mar 20, 2015
Accepted (ET)
Mar 24, 2015 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001266806
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Mar 20, 2015 | S | 98,742 | $13.28 | D | 224,922 | D | |
| COMMON STOCKF2 | Mar 23, 2015 | S | 1,258 | $13.40 | D | 223,664 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option(b)F3 | $4.25 | holding | — | — | — | — | Jan 1, 2017 | Common Stock | 125,000 | 125,000 | D |
| Option(c)F3 | $4.75 | holding | — | — | — | — | Sep 1, 2015 | Common Stock | 150,000 | 150,000 | D |
| Option(d)F3 | $4.75 | holding | — | — | — | — | Jan 1, 2016 | Common Stock | 17,969 | 17,969 | D |
| Option(e)F3 | $5.00 | holding | — | — | — | — | May 1, 2016 | Common Stock | 8,223 | 8,223 | D |
| Option(f)F3 | $5.00 | holding | — | — | — | — | Jan 1, 2017 | Common Stock | 30,625 | 30,625 | D |
| Option(g)F3 | $5.00 | holding | — | — | — | — | Feb 1, 2018 | Common Stock | 23,750 | 23,750 | D |
| Option(h)F3 | $5.00 | holding | — | — | — | — | Nov 1, 2018 | Common Stock | 150,000 | 150,000 | D |
| Option(i)F3 | $5.00 | holding | — | — | — | — | Feb 1, 2019 | Common Stock | 23,750 | 23,750 | D |
| Option(j)F3 | $5.00 | holding | — | — | — | — | Feb 1, 2020 | Common Stock | 53,125 | 53,125 | D |
| Option(k)F3 | $5.00 | holding | — | — | — | — | Feb 1, 2020 | Common Stock | 50,625 | 50,625 | D |
| Option(l)F3 | $5.00 | holding | — | — | — | — | Mar 1, 2021 | Common Stock | 41,563 | 41,563 | D |
| Option(m)F3 | $5.00 | holding | — | — | — | — | Mar 1, 2022 | Common Stock | 29,063 | 29,063 | D |
| Option(n)F4 | $5.00 | holding | — | — | — | — | Apr 1, 2024 | Common Stock | 11,718 | 11,718 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.95, inclusive. The reporting person undertakes to provide to the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter.
- F2The price reported in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.37 to $13.52 inclusive. The reporting person undertakes to provide to the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter.
- F3These are vested employee options currently exercisable.
- F4These options will vest and become exercisable within the next 60 days
Remarks
Excludes unvested employee options in amount of 459,503 shares, which are not exercisable for more than 60 days from this date.